Carbajo Martínez, Rodrigo José Author
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C
- Kettle J.G.
- Bagal S.K.
- Bickerton S.
- Bodnarchuk M.S.
- Boyd S.
- Breed J.
- Carbajo R.J.
- Cassar D.J.
- Chakraborty A.
- Cosulich S.
- Cumming I.
- Davies M.
- Davies N.L.
- Eatherton A.
- Evans L.
- Feron L.
- Fillery S.
- Gleave E.S.
- Goldberg F.W.
- Hanson L.
- Harlfinger S.
- Howard M.
- Howells R.
- Jackson A.
- Kemmitt P.
- Lamont G.
- Lamont S.
- Lewis H.J.
- Liu L.
- Niedbala M.J.
- Phillips C.
- Polanski R.
- Raubo P.
- Robb G.
- Robinson D.M.
- Ross S.
- Sanders M.G.
- Tonge M.
- Whiteley R.
- Wilkinson S.
- Yang J.
- Zhang W.
JOURNAL OF MEDICINAL CHEMISTRY - 1/1/2022
- JCR Impact Factor: 7.3 (2022)
- CiteScore: 11.5 (2021)
- SJR: 1.888 (2021
- SNIP: 1.841 (2021
- JCR 5-year Impact Factor: 7.3
- JCR Categories: CHEMISTRY, MEDICINAL
Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88L265P Mutant Diffuse Large B Cell Lymphoma
- Degorce S.
- Anjum R.
- Bloecher A.
- Carbajo R.
- Dillman K.
- Drew L.
- Halsall C.
- Lenz E.
- Lindsay N.
- Mayo M.
- Pink J.
- Robb G.
- Rosen A.
- Scott J.
- Xue Y.
JOURNAL OF MEDICINAL CHEMISTRY - 1/1/2019
- SJR Quartile: Q1
- JCR Impact Factor: 6.205 (2019)
- CiteScore: 10.6 (2020)
- SJR: 2.093 (2019
- SNIP: 1.686 (2019
- JCR 5-year Impact Factor: 6.521
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q1); Molecular Medicine (Q1)
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists
- Scott J.S.
- Stead D.
- Barlaam B.
- Breed J.
- Carbajo R.J.
- Chiarparin E.
- Cureton N.
- Davey P.R.J.
- Fisher D.I.
- Gangl E.T.
- Grebe T.
- Greenwood R.D.
- Hande S.
- Hatoum-Mokdad H.
- Hughes S.J.
- Hunt T.A.
- Johnson T.
- Kavanagh S.L.
- Klinowska T.C.M.
- Larner C.J.B.
- Lawson M.
- Lister A.S.
- Longmire D.
- Marden S.
- McGuire T.M.
- McMillan C.
- McMurray L.
- Morrow C.J.
- Nissink J.W.M.
- Moss T.A.
- O’Donovan D.H.
- Polanski R.
- Stokes S.
- Thakur K.
- Trueman D.
- Truman C.
- Tucker M.J.
- Wang H.
- Whalley N.
- Wu D.
- Wu Y.
- Yang B.
- Yang W.
Journal of Medicinal Chemistry - 23/2/2023
- CiteScore: 12.3 (2022)
- SJR: 1.805 (2022
- SNIP: 1.655 (2022
Dietary gallic acid and anthocyanin cytotoxicity on human fibrosarcoma HT1080 cells. A study on the mode of action
- Filipiak K.
- Hidalgo M.
- Silvan J.
- Fabre B.
- Carbajo R.
- Pineda-Lucena A.
- Ramos A.
- De Pascual-Teresa B.
- De Pascual-Teresa S.
Food and Function - 1/2/2014
- SJR Quartile: Q1
- JCR Impact Factor: 2.791 (2014)
- CiteScore: 6.4 (2020)
- SJR: 1.022 (2014
- SNIP: 1.074 (2014
- JCR 5-year Impact Factor: 3.046
- JCR Categories: FOOD SCIENCE & TECHNOLOGY
- SJR Categories: Food Science (Q1); Medicine (miscellaneous) (Q1)
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC to Provide Insight into Small Molecule Targeting of BCL6
- McCoull W.
- Cheung T.
- Anderson E.
- Barton P.
- Burgess J.
- Byth K.
- Cao Q.
- Castaldi M.
- Chen H.
- Chiarparin E.
- Carbajo R.
- Code E.
- Cowan S.
- Davey P.
- Ferguson A.
- Fillery S.
- Fuller N.
- Gao N.
- Hargreaves D.
- Howard M.
- Hu J.
- Kawatkar A.
- Kemmitt P.
- Leo E.
- Molina D.
- O'Connell N.
- Petteruti P.
- Rasmusson T.
- Raubo P.
- Rawlins P.
- Ricchiuto P.
- Robb G.
- Schenone M.
- Waring M.
- Zinda M.
- Fawell S.
- Wilson D.
ACS Chemical Biology - 16/11/2018
- SJR Quartile: Q1
- JCR Impact Factor: 4.374 (2018)
- CiteScore: 7.6 (2020)
- SJR: 2.296 (2018
- SNIP: 1.095 (2018
- JCR 5-year Impact Factor: 4.698
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Biochemistry (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1)
Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors
- Gozalbes R.
- Mosulén S.
- Carbajo R.
- Pineda-Lucena A.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN - 7/5/2009
- SJR Quartile: Q1
- JCR Impact Factor: 3.835 (2009)
- CiteScore: 5.3 (2020)
- SJR: 1.085 (2009
- SNIP: 0.99 (2009
- JCR 5-year Impact Factor: 3.583
- JCR Categories: BIOPHYSICS
- SJR Categories: Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)
Detection of natural abundance nitrogen-15 through phosphorus-31 using pulsed field gradients
- Carbajo R.
- López-Ortiz F.
Journal of Magnetic Resonance - 1/1/2001
- JCR Quartile: Q1 (2001)
- SJR Quartile: Q1
- JCR Impact Factor: 2.332 (2022)
- Category normalized Impact: 0.172 (2001)
- CiteScore: 4.5 (2020)
- SJR: 1.398 (2001
- SNIP: 0.788 (2001
- SJR Categories: Biochemistry (Q1); Biophysics (Q1); Condensed Matter Physics (Q1); Nuclear and High Energy Physics (Q1)
- Scopus
- ORCID
- Web of Science
Design of rigid protein-protein interaction inhibitors enables targeting of undruggable Mcl-1
- Hargreaves D.
- Carbajo R.J.
- Bodnarchuk M.S.
- Embrey K.
- Rawlins P.B.
- Packer M.
- Degorce S.L.
- Hird A.W.
- Johannes J.W.
- Chiarparin E.
- Schade M.
Proceedings of the National Academy of Sciences of the United States of America - 23/5/2023
- CiteScore: 19.2 (2022)
- SJR: 4.026 (2022
- SNIP: 2.765 (2022
Deciphering Biosynthesis of the RNA Polymerase Inhibitor Streptolydigin and Generation of Glycosylated Derivatives
- Olano C.
- Gómez C.
- Pérez M.
- Palomino M.
- Pineda-Lucena A.
- Carbajo R.
- Braña A.
- Méndez C.
- Salas J.
CHEMISTRY and BIOLOGY - 30/10/2009
10.1016/j.chembiol.2009.09.015
- JCR Impact Factor: 6.523 (2009)
- CiteScore: 5.43 (2015)
- JCR 5-year Impact Factor: 6.373
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery
- Gozalbes R.
- Carbajo R.
- Pineda-Lucena A.
CURRENT MEDICINAL CHEMISTRY - 18/6/2010
- SJR Quartile: Q1
- JCR Impact Factor: 4.63 (2010)
- CiteScore: 6.9 (2020)
- SJR: 1.7 (2010
- SNIP: 1.406 (2010
- JCR 5-year Impact Factor: 4.961
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Molecular Medicine (Q1); Pharmacology (Q1)
This author has no conferences.
This author has no patents.
Erratum: Free ligand 1D NMR conformational signatures to enhance structure based drug design of a Mcl-1 inhibitor (AZD5991) and other synthetic macrocycles (Journal of Medicinal Chemistry (2019) 62:21 (9418-9437) DOI: 10.1021/acs.jmedchem.9b00716)
- Balazs A.Y.S.
- Carbajo R.J.
- Davies N.L.
- Dong Y.
- Hird A.W.
- Johannes J.W.
- Lamb M.L.
- McCoull W.
- Raubo P.
- Robb G.R.
- Packer M.J.
- Chiarparin E.
JOURNAL OF MEDICINAL CHEMISTRY - 1/1/2021
- JCR Impact Factor: 8.039 (2021)
- CiteScore: 10.6 (2020)
- SJR: 2.01 (2020
- SNIP: 1.791 (2020
- JCR 5-year Impact Factor: 7.897
- JCR Categories: CHEMISTRY, MEDICINAL
h index
Scopus: 24
Web of Science: 5
i10 index
Scopus: 47
Web of Science: 4
Author profiles
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym PB96-1503Since: October 1, 1997Until: October 1, 1998Funded by: MECFunding / grant amount: 12,020.24 EURRole: Investigador